Microbiota, Metabolome and Nutrition: an 'Artificially Intelligent' Way to Personalized Nutrition - Trial NCT06420843
Access comprehensive clinical trial information for NCT06420843 through Pure Global AI's free database. This phase not specified trial is sponsored by Istituto Clinico Humanitas and is currently Recruiting. The study focuses on IBS - Irritable Bowel Syndrome. Target enrollment is 48 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
Istituto Clinico Humanitas
Timeline & Enrollment
N/A
Dec 22, 2021
Dec 31, 2024
Primary Outcome
Microbiome
Summary
Intervention:
 
 (Weeks 1-2, Visit 3-4) - Starting from the second week after the date of consent, patients
 with IBS will be randomized 1:1 into two groups. The first group (20 patients) will receive
 one week of a low FODMAP supplemented with fermented milk followed by one week of a low
 FODMAP content supplemented with fermented beans. The second group (20 patients) will receive
 a low FODMAP diet supplemented for one week with fermented beans followed by a second week of
 a diet with a low FODMAP diet supplemented with fermented milk. The microbiome of the
 patients will be evaluated after the first and second weeks along with data related to
 weight. After the second week, the metabolome and physical characteristics. The enrollment
 period will last for one year. The analysis of clinical data will be completed within one
 year after patient enrollment. Analysis of laboratory data will be performed in parallel.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT06420843
Non-Device Trial